The Opioid Epidemic NOVEMBER 29, 2018 Jane Liebschutz, MD, MPH, FACP

Slides:



Advertisements
Similar presentations
Dosing and patient management requirements during induction, stabilization, and detoxification with buprenorphine Matthew A. Torrington MD Clinical Research.
Advertisements

OPIOIDS I. Where do they come from? / synthesized in 1803
DSM – 5 Substance-Related and Addictive Disorders
 The term narcotic is used for the sedative agent, For pain control medications of both narcotic and non- narcotic varieties. Today, the term "narcotic"
Medication Assisted Treatment Michael Palladini, RPh MBA CAC
Facts In 2008, an estimated 20.1 million Americans aged 12 or older were current (past-month) illicit drug users. (8.0% of the population) million.
Sublingual Buprenorphine and Pain
Chapter 13 Opioids.
John R. Kasich, Governor Tracy J. Plouck, Director Andrea Boxill, Deputy Director Andrea Boxill, Deputy Director Governor’s Cabinet Opiate Action Team.
Medical Model of Addiction
Buprenorphine in the treatment of addiction Matthew A. Torrington MD Clinical Research Physician UCLA: Integrated Substance Abuse Programs Matrix Institute.
DOUGHNUTSDOUGHNUTS. Opioid Agonist Therapy The Skinny on Methadone et al.
Assessment of Substance Use Disorders
Copyright © 2007 by The McGraw-Hill Companies, Inc. All rights reserved. Chapter 17 Substance-Related Disorders – Focus on Alcoholism.
BUPRENORPHINE TREATMENT: A TRAINING FOR MULTIDISCIPLINARY ADDICTION PROFESSIONALS Module III – Buprenorphine 101.
FIVE MINUTES TO MAKE A DIFFERENCE Presentation by: Mark Barnes.
Opiates. Opiates: what, exactly are they?!? Opiates are used to induce sleep and alleviate pain. They act as depressants to the central nervous system.
Buprenorphine and the NIDA CTN: Research to Practice Walter Ling & Richard Rawson ISAP/UCLA XIII World Congress of Psychiatry September 14, 2005 Cairo,
Module 1 General introduction to substitution treatment.
Chapter 8 Narcotics. Historical Perspectives The term narcotics is from the Greek word meaning stupor Throughout history opium figured prominently in.
Buprenorphine Treatment for Opioid Dependence CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for.
Opiate Management Douglas Keehn DO Adjunct Assistant Clinical Professor University Wisconsin Board Certified Anesthesia & Pain Management.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny,
Buprenorphine {Suboxone®, Subutex®}
UCLA Brain Institute Outreach Adrina Kocharian and Rachel Oseas.
Drugs and Toxicology Chapter 9. Drugs A substance (either natural or synthetic) that is used to produce effects (either physiological or psychological)
Pain Management: Narcotics, Implantable Therapies Maher Fattouh MD Adjunct Assistant Clinical Professor University Wisconsin Medical Director, Advanced.
Chronic Pain Management Harald Lausen, DO, MA FCM Clerkship SIU School of Medicine.
Suboxone and Opioid Trends Joseph Merrill M.D., M.P.H. University of Washington June 16, 2009.
Medications for the Treatment of Opioid Addiction Robert P. Schwartz, M.D. Friends Research Institute.
December 10, 2015 Arthur Robin Williams MD MBE American Academy of Addiction Psychiatry Division on Substance Abuse Department of Psychiatry, Columbia.
Responding to the Opioid Addiction Epidemic Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation Inc. Executive Director, Physicians for.
The Prescription Opioid and Heroin Crisis: An Epidemic of Addiction
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D. Chief Medical Officer, Phoenix House Foundation.
Responding to the Prescription Opioid and Heroin Crisis: An Epidemic of Addiction Andrew Kolodny, M.D.. Executive Director, Physicians for Responsible.
Medication-Assisted Treatment
Current Concepts in Pain Management
The Rise and Fall (. ) of the Opioid Epidemic Michael Saxe, M. D
Center for Social Work Research The University of Texas at Austin
Opiate Receptors in the body
Medi-cal covered inpt tx in SoCo?
Medication-Assisted Therapy at Coleman Profession Services
Buy Pain Killer Online Michigan
Acute Pain Management for Patients Receiving Buprenorphine Therapy
Methadone and Suboxone
Addressing the Opioid Epidemic
McLean Hospital Division of Alcohol and Drug Abuse
Case Presentations.
Drugs.
Understanding the Opioid Epidemic
Opioids – A Pharmaceutical Perspective on Prescription Drugs
MEDICATION ASSISTED TREATMENT for OPIATE ADDICTION
DSM-IV-TR, APA, 2000 Criteria for Substance Dependence:
Opiates: Addiction to Recovery Section 1
Medication-Assisted Treatment 101: Breaking the Stigma
Substance Use Disorders
Pain Management: Patients Maintained on Buprenorphine
Todd Davis, MD, MMM EVP & CMO, CaroMont Health
Assessing Opioid Use Disorder, part 1
Introduction to Opioids
SIHC MAT PROGRAM Hafifa Shabaik, PhD, RN, Quality Measures RN/Program Coordinator Young Suh, MD Medical Director/Program Director Southern Indian Health.
Medication Assisted Treatment: Changing the Trajectory of the Opioid Epidemic
Gender Issues and Addiction
Medically assisted treatment
Medication Assisted Treatment of Opioid Use Disorder
The Silent Killer in America
THE HISTORY OF OPIUM Steve Weaver MD.
Opioid Crisis What is the Big Deal?
Bassett-UMass MAT ECHO.
Opiate misuse among our seniors
Presentation transcript:

The Opioid Epidemic NOVEMBER 29, 2018 Jane Liebschutz, MD, MPH, FACP PROFESSOR OF MEDICINE Chief, DIVISION OF GENERAL INTERNAL MEDICINE Upmc, university of Pittsburgh @liebschutz

Learning Objectives Historical perspective on opioid prescribing and addiction Criteria for diagnosis of opioid use disorder Impact of opioid epidemic Treatment of opioid use disorder The opioid epidemic

Discovery of Morphine, 1806 Friedrich Wilhelm Adam Serturner, 1783-1841 Morphine is named for Morpheus, God of Sleep and Dreams 15 mg standard dose The opioid epidemic

Michael S. 1864: Civil War battle injury Morphine treated his pain The opioid epidemic

Michael S. 1899: Chronic cough from industrial exposure Di-acetylmorphine from Bayer The opioid epidemic

Harrison Act of 1914 Combat addictive properties of medicinal opioids (heroin, morphine, codeine) Regulate nonmedical opioid use Made possession without prescription illegal The opioid epidemic

Opioids Natural and Semi-synthentic Synthetic Morphine Diacetylmorphine (Heroin) Oxycodone Hydrocodone Hydromorphone Oxymorphone So let’s talk a little bit about opioids in terms of their pharmacology so we get a better appreciation for the efficacy and safety of opioids, and are they all the same or are they different? It really starts with the opiates, morphine and codeine, which come from opium. And when you take these molecules, you take them to the lab, and you alter them some, you can create semi-synthetic opioids like hydrocodone, hydromorphone, oxycodone, oxymorphone, and diacetylmorphine, which is heroin.   The important thing to remember is that when we check urine drug tests, we ask the lab to check whether or not there are opioids or opiates in the urine. And we’re checking for morphine and codeine. However, the semi-synthetics that came from morphine and codeine can revert back to morphine and codeine and turn your urine positive for an opiate. That’s different, however, than the synthetic opioids like methadone, meperidine, and fentanyl. These never came from an opiate, namely morphine and codeine, and they will never convert back to morphine and codeine, and they will never turn your urine positive for an opiate. All of these opioids, whether they’re semi-synthetic or synthetic, can be tested for specifically with immunoassays. And you’re going to hear much more about urine drug testing in the next presentation. Synthetic Methadone Meperidine (Demerol) Fentanyl Buprenorphine The opioid epidemic

1974: Michael S. Exposed to heroin and drugs during deployment in Vietnam Treated with methadone The opioid epidemic

Heroin, 1960s – 1970s Mostly minority communities Returning Vietnam vets Methadone approved 1972 The opioid epidemic

Undertreatment of Pain 1970s-1980s Undertreated cancer pain The opioid epidemic

“Addiction Rare in Patients Treated with Narcotics” January 10, 1980 N Engl J Med 1980; 302:123 The opioid epidemic

Wave 1: Increase Opioid Prescribing 1996: Oxycontin marketed aggressively by Purdue 2001 Joint Commission: Pain as a 5th vital sign Compton 2006 Drug Alc Depend 81:103-107 The opioid epidemic

Michael S. 1997: Chronic back pain from construction accident Disabled Prescribed OxyContin to help with pain The opioid epidemic

Parallel Rise in Opioid Prescriptions, Addiction, and Overdose MMWR November 4, 2011 60(43);1487-1492 The opioid epidemic

Addiction Is a Brain Disease Drugs hijack brain reward circuits Develop tolerance and withdrawal Learned behavior “Habit” Volkow, N Engl J Med 2016; 374:363-371 Lewis, N Engl J Med 2018; 379:1551-1560 The opioid epidemic

What Is Opioid Use Disorder? DSM-V criteria Use in larger amounts or over a longer period than intended Unsuccessful efforts to cut down/persistent use A great deal of time spent getting, using, or recovering from use Craving, or a strong desire to use Recurrent use resulting in failure to fulfill major obligations at work, school, or home Continued use despite social or interpersonal problems caused by use The opioid epidemic

What Is Opioid Use Disorder? (Continued) Social, work, recreational activities given up or reduced Use in situations in which it is physically hazardous Continued use despite physical or psychological harm Withdrawal Classic withdrawal Opioids relieve withdrawal symptoms Tolerance Need for increased amount to achieve same effect Decreased effect with same amount 2 or more in 12 months; 2-3=mild, 4-5=moderate, 6 or more=severe The opioid epidemic

A small number of physicians prescribed an outsized number of pills. Pill Mills A small number of physicians prescribed an outsized number of pills. The opioid epidemic

Prescription Drug Monitoring Programs State based - – to “catch” the patients who are “doctor shopping” 2000s 2010: 27 states 2018: 49 states Law enforcement aggressively pursue prescribers Shut down pill mills The opioid epidemic

Michael S. 2010: Unemployed coal miner When OxyContin supply cut off, started buying heroin Injects 3-4 times daily Two overdoses Girlfriend works as a nurse Watches kids when girlfriend works The opioid epidemic

Wave 2: Heroin Import from Mexican cartels Heroin deaths on the rise Marketing directly to suburban white customers Heroin deaths on the rise Compton, N Engl J Med 2016;374:154-63 The opioid epidemic

Heroin Use Climbed Then Stablized The opioid epidemic

Wave 3: Fentanyl 50 times more potent than heroin Manufactured in China and elsewhere Mixed with heroin and other drugs to increase “high” The opioid epidemic

Michael S. 2016: Multiple nonfatal overdoses No treatment slots in his rural county Died of fentanyl overdose The opioid epidemic

>72,000 drug overdose deaths 2017 The opioid epidemic

Mortality Rates Rise for U.S. Whites All-cause mortality, ages 45-54 for U.S. White non-Hispanics (USW), U.S. Hispanics (USH), and six comparison countries: France (FRA) Germany (GER) United Kingdom (UK), Canada (CAN) Australia (AUS) Sweden (SWE) Deaths of Despair: Overdose Alcoholism Suicide Anne Case, and Angus Deaton PNAS 2015;112:49:15078-15083 The opioid epidemic ©2015 by National Academy of Sciences

Impact on Families 2.8 million custodial grandparents raising 4.5 million children Increase of 7% since 2009 Parent support groups: www.palgroup.org https://www.learn2cope.org/ The opioid epidemic

Neonatal Withdrawal Syndrome (NOWs) Hyperactivity of central and autonomic nervous system and gastrointestinal tract 2009: 1.19/1000 live births 2012: 5.63/1000 live births Rural > Urban West Virginia: 50/1000 live births The opioid epidemic

Types of Treatments: Medications Behavioral Therapies The opioid epidemic

Medication Treatments: Full Agonists Methadone Morphine* Partial Agonists Buprenorphine (Suboxone) Antagonists Naltrexone (Vivitrol) *off-label Naloxone (Narcan) The opioid epidemic

Buprenorphine (Partial Agonist) Naltrexone (Antagonist) Clinical Setting Clinical Setting Methadone (Agonist) Buprenorphine (Partial Agonist) Naltrexone (Antagonist) Any outpatient setting DEA waiver for outpatient Up to 30 day supply Federally licensed facility Daily observed dosing Any licensed prescriber Oral (daily), injectable (4 weeks) The opioid epidemic

All Cause Mortality Rates In and Out of Methadone and Buprenorphine Treatment, 1974-2016 All Cause Mortality rates per 1000 Methadone vs. No Rx 11.3 vs. 36.1 Buprenorphine vs. No Rx 4.3 vs. 9.5 Luis Sordo et al. BMJ 2017;357:bmj.j1550 The opioid epidemic

Massachusetts Chapter 55 Adjusted* Hazard for Opioid-Related Mortality By Monthly Receipt of Treatment in Post-Overdose Period N=17,568 Buprenorphine 0.3 (0.2-0.5) Methadone 0.3 (0.2-0.6) 0.5 (0.1-2.1) Naltrexone *Adjusted for: age, sex, depression DX, anxiety DX, incarceration, detoxification, baseline opioid and benzodiazepine RX, and monthly post-overdose receipt of benzodiazepines, opioids, detoxification and short- and long-term residential treatment. 0.1 0.5 1 2 3 4 5 On Treatment LaRochelle, Ann. Int Med 2018 The opioid epidemic

Cognitive Based Therapy Contingency Management Behavioral Therapies – Adjunct to Pharmacotherapy Cognitive Based Therapy Contingency Management The opioid epidemic

Adjuvant Psychosocial Rx/CBT Risk Ratio: 1.03 (0.98-1.07) Amato 2011 Cochrane Systematic Review The opioid epidemic

Key Points: OPIOIDS Balance between therapeutic use and addiction Brain adaptation Bending the mortality curve Impacts children and families Medication treatment saves lives The opioid epidemic

Thank You Twitter: @Liebschutz Email: Liebschutzjm@upmc.edu The opioid epidemic